Cargando…
Thalidomide and lenalidomide for recurrent ovarian cancer: A systematic review of the literature
The present review aimed to assess the safety and efficacy of thalidomide and lenalidomide, two immunomodulatory drugs with anti-angiogenic properties, in women with recurrent ovarian, fallopian tube, and primary peritoneal cancer. A systematic review of the literature was conducted whereby Medline...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587990/ https://www.ncbi.nlm.nih.gov/pubmed/28927084 http://dx.doi.org/10.3892/ol.2017.6578 |